228 related articles for article (PubMed ID: 25869677)
1. ZAK induces cardiomyocyte hypertrophy and brain natriuretic peptide expression via p38/JNK signaling and GATA4/c-Jun transcriptional factor activation.
Hsieh YL; Tsai YL; Shibu MA; Su CC; Chung LC; Pai P; Kuo CH; Yeh YL; Viswanadha VP; Huang CY
Mol Cell Biochem; 2015 Jul; 405(1-2):1-9. PubMed ID: 25869677
[TBL] [Abstract][Full Text] [Related]
2. Gelsolin (GSN) induces cardiomyocyte hypertrophy and BNP expression via p38 signaling and GATA-4 transcriptional factor activation.
Hu WS; Ho TJ; Pai P; Chung LC; Kuo CH; Chang SH; Tsai FJ; Tsai CH; Jie YC; Liou YM; Huang CY
Mol Cell Biochem; 2014 May; 390(1-2):263-70. PubMed ID: 24505034
[TBL] [Abstract][Full Text] [Related]
3. The mixed-lineage kinase 1-3 signalling pathway regulates stress response in cardiac myocytes via GATA-4 and AP-1 transcription factors.
Ola A; Kerkelä R; Tokola H; Pikkarainen S; Skoumal R; Vuolteenaho O; Ruskoaho H
Br J Pharmacol; 2010 Feb; 159(3):717-25. PubMed ID: 20067472
[TBL] [Abstract][Full Text] [Related]
4. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.
Kang S; Chemaly ER; Hajjar RJ; Lebeche D
J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta induces the expression of ANF and hypertrophic growth in cultured cardiomyoblast cells through ZAK.
Huang CY; Kuo WW; Chueh PJ; Tseng CT; Chou MY; Yang JJ
Biochem Biophys Res Commun; 2004 Nov; 324(1):424-31. PubMed ID: 15465036
[TBL] [Abstract][Full Text] [Related]
6. ZAK re-programs atrial natriuretic factor expression and induces hypertrophic growth in H9c2 cardiomyoblast cells.
Huang CY; Chueh PJ; Tseng CT; Liu KY; Tsai HY; Kuo WW; Chou MY; Yang JJ
Biochem Biophys Res Commun; 2004 Nov; 324(3):973-80. PubMed ID: 15485649
[TBL] [Abstract][Full Text] [Related]
7. Distinct regulation of B-type natriuretic peptide transcription by p38 MAPK isoforms.
Koivisto E; Kaikkonen L; Tokola H; Pikkarainen S; Aro J; Pennanen H; Karvonen T; Rysä J; Kerkelä R; Ruskoaho H
Mol Cell Endocrinol; 2011 May; 338(1-2):18-27. PubMed ID: 21354263
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells.
Liu CJ; Cheng YC; Lee KW; Hsu HH; Chu CH; Tsai FJ; Tsai CH; Chu CY; Liu JY; Kuo WW; Huang CY
Mol Cell Biochem; 2008 Jun; 313(1-2):167-78. PubMed ID: 18398669
[TBL] [Abstract][Full Text] [Related]
9. ZAK induces MMP-2 activity via JNK/p38 signals and reduces MMP-9 activity by increasing TIMP-1/2 expression in H9c2 cardiomyoblast cells.
Cheng YC; Kuo WW; Wu HC; Lai TY; Wu CH; Hwang JM; Wang WH; Tsai FJ; Yang JJ; Huang CY; Chu CH
Mol Cell Biochem; 2009 May; 325(1-2):69-77. PubMed ID: 19184368
[TBL] [Abstract][Full Text] [Related]
10. ZAK inhibits human lung cancer cell growth via ERK and JNK activation in an AP-1-dependent manner.
Yang JJ; Lee YJ; Hung HH; Tseng WP; Tu CC; Lee H; Wu WJ
Cancer Sci; 2010 Jun; 101(6):1374-81. PubMed ID: 20331627
[TBL] [Abstract][Full Text] [Related]
11. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
Molkentin JD
Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
[TBL] [Abstract][Full Text] [Related]
13. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases.
Sprowles A; Robinson D; Wu YM; Kung HJ; Wisdom R
Exp Cell Res; 2005 Aug; 308(2):459-68. PubMed ID: 15950217
[TBL] [Abstract][Full Text] [Related]
14. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
15. Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation.
Lin EQ; Irvine JC; Cao AH; Alexander AE; Love JE; Patel R; McMullen JR; Kaye DM; Kemp-Harper BK; Ritchie RH
PLoS One; 2012; 7(4):e34892. PubMed ID: 22506056
[TBL] [Abstract][Full Text] [Related]
16. Tissue distribution and functional expression of a cDNA encoding a novel mixed lineage kinase.
Bloem LJ; Pickard TR; Acton S; Donoghue M; Beavis RC; Knierman MD; Wang X
J Mol Cell Cardiol; 2001 Sep; 33(9):1739-50. PubMed ID: 11549352
[TBL] [Abstract][Full Text] [Related]
17. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
[TBL] [Abstract][Full Text] [Related]
18. A peptide from a ras effector-domain blocks ras-dependent cardiac hypertrophy in myocytes.
Deng L; Boujdir M; Tremontano A; Pincus MR; El-Sherif N
Ann Clin Lab Sci; 2009; 39(4):351-60. PubMed ID: 19880762
[TBL] [Abstract][Full Text] [Related]
19. Reoxygenation after severe hypoxia induces cardiomyocyte hypertrophy in vitro: activation of CREB downstream of GSK3beta.
El Jamali A; Freund C; Rechner C; Scheidereit C; Dietz R; Bergmann MW
FASEB J; 2004 Jul; 18(10):1096-8. PubMed ID: 15155564
[TBL] [Abstract][Full Text] [Related]
20. ASK1 regulates cardiomyocyte death but not hypertrophy in transgenic mice.
Liu Q; Sargent MA; York AJ; Molkentin JD
Circ Res; 2009 Nov; 105(11):1110-7. PubMed ID: 19815822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
